Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD study protocol for a randomized controlled trial
Standard
Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD study protocol for a randomized controlled trial. / Schäfer, Ingo; Chuey-Ferrer, Laycen; Hofmann, Arne; Lieberman, Peter; Mainusch, Günter; Lotzin, Annett.
in: BMC PSYCHIATRY, Jahrgang 17, Nr. 1, 16.03.2017, S. 95.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD study protocol for a randomized controlled trial
AU - Schäfer, Ingo
AU - Chuey-Ferrer, Laycen
AU - Hofmann, Arne
AU - Lieberman, Peter
AU - Mainusch, Günter
AU - Lotzin, Annett
PY - 2017/3/16
Y1 - 2017/3/16
N2 - BACKGROUND: Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based treatment for PTSD. However, it is unclear whether EMDR shows the same effectiveness in patients with substance use disorders (SUD) and comorbid PTSD. In this trial, we examine the effectiveness of EMDR in reducing PTSD symptoms in patients with SUD and PTSD.METHODS/DESIGN: We conduct a single-blinded RCT among 158 patients with SUD and comorbid PTSD admitted to a German addiction rehabilitation center specialized for the treatment of patients with SUD and comorbid PTSD. Patients are randomized to receive either EMDR, added to SUD rehabilitation and non-trauma-focused PTSD treatment (TAU), or TAU alone. The primary outcome is change from baseline in PTSD symptom severity as measured by the Clinician-Administered PTSD Scale at 6-month follow-up. Secondary outcomes are change from baseline in substance use, addiction-related problems, depressive symptoms, dissociative symptoms, emotion dysregulation and quality of life. Assessments are carried out by blinded raters at admission, at end of treatment, and at 3- and 6-month follow-up. We expect that EMDR plus TAU will be more effective in reducing PTSD symptoms than TAU alone. Mixed models will be conducted using an intention-to-treat and per-protocol approach.DISCUSSION: This study aims to expand the knowledge about the effectiveness of EMDR in patients with SUD and comorbid PTSD. The expected finding of the superiority of EMDR in reducing PTSD symptoms compared to non-trauma-focused PTSD treatment may enhance the use of trauma-focused treatment approaches for patients with SUD and co-morbid PTSD.TRIAL REGISTRATION: German Clinical Trials Register: DRKS00009007 ; U1111-1172-9213. Retrospectively registered 01 Juni 2016.
AB - BACKGROUND: Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based treatment for PTSD. However, it is unclear whether EMDR shows the same effectiveness in patients with substance use disorders (SUD) and comorbid PTSD. In this trial, we examine the effectiveness of EMDR in reducing PTSD symptoms in patients with SUD and PTSD.METHODS/DESIGN: We conduct a single-blinded RCT among 158 patients with SUD and comorbid PTSD admitted to a German addiction rehabilitation center specialized for the treatment of patients with SUD and comorbid PTSD. Patients are randomized to receive either EMDR, added to SUD rehabilitation and non-trauma-focused PTSD treatment (TAU), or TAU alone. The primary outcome is change from baseline in PTSD symptom severity as measured by the Clinician-Administered PTSD Scale at 6-month follow-up. Secondary outcomes are change from baseline in substance use, addiction-related problems, depressive symptoms, dissociative symptoms, emotion dysregulation and quality of life. Assessments are carried out by blinded raters at admission, at end of treatment, and at 3- and 6-month follow-up. We expect that EMDR plus TAU will be more effective in reducing PTSD symptoms than TAU alone. Mixed models will be conducted using an intention-to-treat and per-protocol approach.DISCUSSION: This study aims to expand the knowledge about the effectiveness of EMDR in patients with SUD and comorbid PTSD. The expected finding of the superiority of EMDR in reducing PTSD symptoms compared to non-trauma-focused PTSD treatment may enhance the use of trauma-focused treatment approaches for patients with SUD and co-morbid PTSD.TRIAL REGISTRATION: German Clinical Trials Register: DRKS00009007 ; U1111-1172-9213. Retrospectively registered 01 Juni 2016.
KW - Adult
KW - Combined Modality Therapy
KW - Comorbidity
KW - Evidence-Based Medicine
KW - Eye Movement Desensitization Reprocessing
KW - Female
KW - Follow-Up Studies
KW - Germany
KW - Humans
KW - Interview, Psychological
KW - Male
KW - Middle Aged
KW - Quality of Life
KW - Rehabilitation Centers
KW - Single-Blind Method
KW - Stress Disorders, Post-Traumatic
KW - Substance-Related Disorders
KW - Treatment Outcome
KW - Young Adult
KW - Journal Article
KW - Randomized Controlled Trial
U2 - 10.1186/s12888-017-1255-9
DO - 10.1186/s12888-017-1255-9
M3 - SCORING: Journal article
C2 - 28302084
VL - 17
SP - 95
JO - BMC PSYCHIATRY
JF - BMC PSYCHIATRY
SN - 1471-244X
IS - 1
ER -